Bausch + Lomb Q1 Earnings Forecast Boosted by HC Wainwright

Bausch + Lomb (NYSE:BLCO) CAO Frederick Munsch Sells 112,015 Shares of Company Stock

Bausch + Lomb Corporation (NYSE:BLCO - Get Free Report) CAO Frederick Munsch sold 112,015 shares of Bausch + Lomb stock in a transaction dated Thursday, October 29th. The stock was sold at an average price of $20.48, for a total value of $2,294,067.20. Following the sale, the chief accounting officer directly owned 45,831 shares in the company, valued at approximately $938,618.88. This trade represents a 70.96% decrease in their ownership of the…

Bausch + Lomb Corporation (BLCO) Stock Analysis: Navigating Healthcare with 8.21% Upside Potential

Bausch + Lomb Corporation (NYSE: BLCO), a Canada-based leader in the healthcare sector, particularly within the medical instruments and supplies industry, is capturing the attention of investors looking for opportunities in the eye health domain. With a market capitalization of $7.15 billion, the company stands as a significant player, offering a diverse range of products and services across its Vision Care, Pharmaceuticals, and Surgical segment…